Trimodality treatment in Stage III nonsmall cell lung carcinoma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference32 articles.
1. Revisions in the international system for staging lung cancer;Mountain;Chest.,1997
2. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications;Andre;J Clin Oncol.,2000
3. Ras genes;Barbacid;Annu Rev Biochem.,1987
4. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung;Slebos;N Engl J Med.,1990
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers;Clinical Cancer Research;2022-06-21
2. Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer;Journal of the American Chemical Society;2022-04-13
3. Use of biomarkers in lung cancer diagnosis, prognosis, and treatment;Lung Cancer and Imaging;2019-12
4. Pet ownership and the risk of dying from lung cancer, findings from an 18 year follow-up of a US national cohort;Environmental Research;2019-06
5. Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy;Cancer Medicine;2018-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3